BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Diagnosis
39 results:

  • 1. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
    Wang WN; Liu XT; Liang YM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
    [No Abstract]    [Full Text] [Related]  

  • 2. Advanced renal pelvis carcinoma patient with an erbb2 insertion mutation: a case report.
    Shang P; Lou C; Yin L; Tao C; Dong Y; Yang G; Yuan Z
    J Int Med Res; 2023 Nov; 51(11):3000605231204502. PubMed ID: 37917812
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Channel-Dimensional Feature-Reconstructed Deep Learning Model for Predicting Breast Cancer Molecular Subtypes on Overall b-Value Diffusion-Weighted MRI.
    Zhou XX; Zhang L; Cui QX; Li H; Sang XQ; Zhang HX; Zhu YM; Kuai ZX
    J Magn Reson Imaging; 2024 Apr; 59(4):1425-1435. PubMed ID: 37403945
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
    Sahu DK; Singh N; Das M; Rawat J; Gupta DK
    Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Risk assessment for PFOA and kidney cancer based on a pooled analysis of two studies.
    Steenland K; Hofmann JN; Silverman DT; Bartell SM
    Environ Int; 2022 Sep; 167():107425. PubMed ID: 35905598
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical characteristics and prognostic factors of patients with non-small cell lung cancer having her2 alterations.
    Zhuo X; Guo H; Ma J; Lai J; Liu L; Yin K; Zhao J; Wang J; Jiang F; Xu W; Yuan X; Lin X; Fu G
    J Cancer Res Clin Oncol; 2023 May; 149(5):2029-2039. PubMed ID: 35829744
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the Treatment of Cancer: A Review.
    Unnisa A; Chettupalli AK; Hussain T; Kamal MA
    Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study.
    Akinyemiju T; Oyekunle T; Salako O; Gupta A; Alatise O; Ogun G; Adeniyi A; Deveaux A; Hall A; Ayandipo O; Olajide T; Olasehinde O; Arowolo O; Adisa A; Afuwape O; Olusanya A; Adegoke A; Tollefsbol TO; Arnett D; Muehlbauer MJ; Newgard CB; ; Daramola A
    Clin Breast Cancer; 2022 Jun; 22(4):e463-e472. PubMed ID: 34980540
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinicopathological significance of claspin overexpression and its efficacy as a novel biomarker for the diagnosis of urothelial carcinoma.
    Kobayashi G; Hayashi T; Sentani K; Babasaki T; Sekino Y; Inoue S; Uraoka N; Hanamoto M; Nose H; Teishima J; Oue N; Matsubara A; Sasaki N; Yasui W
    Virchows Arch; 2022 Mar; 480(3):621-633. PubMed ID: 34842980
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A Triptolide Loaded her2-Targeted Nano-Drug Delivery System Significantly Suppressed the Proliferation of her2-Positive and BRAF Mutant Colon Cancer.
    Yalikong A; Li XQ; Zhou PH; Qi ZP; Li B; Cai SL; Zhong YS
    Int J Nanomedicine; 2021; 16():2323-2335. PubMed ID: 33776436
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Signet ring cell carcinoma of rectum metastasizing to synchronous renal cell carcinoma: a case report.
    Krsteska B; Jovanovic R; Eftimov A; Ilievski B; Hadzi-Mancev D; Osmani B; Kostadinova-Kunovska S
    J Med Case Rep; 2021 Mar; 15(1):123. PubMed ID: 33731191
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Expression of functional E-selectin ligands on the plasma membrane of carcinoma cells correlates with poor prognosis in clear cell renal cell carcinoma.
    Tanio M; Muramoto A; Hoshino H; Murahashi M; Imamura Y; Yokoyama O; Kobayashi M
    Urol Oncol; 2021 May; 39(5):302.e9-302.e18. PubMed ID: 33676847
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Epidemiology and biological characteristics of male breast cancer in Italy.
    Mangone L; Ferrari F; Mancuso P; Carrozzi G; Michiara M; Falcini F; Piffer S; Filiberti RA; Caldarella A; Vitale F; Tumino R; Brustolin A; Tagliabue G; Giorgi Rossi P; Ottini L
    Breast Cancer; 2020 Jul; 27(4):724-731. PubMed ID: 32114665
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Osteopontin-targeted probe detects orthotopic breast cancers using optoacoustic imaging.
    Samykutty A; Thomas A; McNally M; Chiba A; McNally LR
    Biotech Histochem; 2018; 93(8):608-614. PubMed ID: 30260254
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Association of hypertension and treatment outcomes in advanced stage non-small cell lung cancer patients treated with bevacizumab or non-bevacizumab containing regimens.
    Yan LZ; Dressler EV; Adams VR
    J Oncol Pharm Pract; 2018 Apr; 24(3):209-217. PubMed ID: 29284349
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Characteristics and prognosis of breast cancer after liver or kidney transplantation.
    Jeong IJ; Lee SG; Kim YH; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
    Breast Cancer Res Treat; 2018 Jan; 167(1):101-106. PubMed ID: 28914398
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Effect of Vitamin D and Calcium Supplementation on Cancer Incidence in Older Women: A Randomized Clinical Trial.
    Lappe J; Watson P; Travers-Gustafson D; Recker R; Garland C; Gorham E; Baggerly K; McDonnell SL
    JAMA; 2017 Mar; 317(12):1234-1243. PubMed ID: 28350929
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992-2013.
    Noone AM; Cronin KA; Altekruse SF; Howlader N; Lewis DR; Petkov VI; Penberthy L
    Cancer Epidemiol Biomarkers Prev; 2017 Apr; 26(4):632-641. PubMed ID: 27956436
    [No Abstract]    [Full Text] [Related]  

  • 19. Tumor detection using magnetosome nanoparticles functionalized with a newly screened EGFR/her2 targeting peptide.
    Xiang Z; Yang X; Xu J; Lai W; Wang Z; Hu Z; Tian J; Geng L; Fang Q
    Biomaterials; 2017 Jan; 115():53-64. PubMed ID: 27888699
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Gonadal function in boys with newly diagnosed cancer before the start of treatment.
    Wigny KM; van Dorp W; van der Kooi AL; de Rijke YB; de Vries AC; Smit M; Pluijm SM; van den Akker EL; Pieters R; Laven JS; van den Heuvel-Eibrink MM
    Hum Reprod; 2016 Nov; 31(11):2613-2618. PubMed ID: 27680030
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.